Inj Tazocef
Weight: 1.125 mg
Composition: Inj Tazocef 1.125 g contains:
Inj Tazocef 1.125 g is a broad-spectrum antibiotic designed for severe bacterial infections. Combining ceftriaxone with tazobactam enhances its effectiveness by counteracting beta-lactamase enzymes produced by resistant bacteria. It is used in treating various bacterial infections of the respiratory tract, urinary tract, abdomen, and skin.
Common side effects may include:
Rare but serious side effects:
Inj Tazocef 1.125 g is indicated for severe bacterial infections, particularly those caused by beta-lactamase-producing organisms resistant to standard antibiotics.
Possible substitutes for Inj Tazocef 1.125 g in Nepal include:
